Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures-Reference-Cited by-同舟云学术

Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures

Published:2018-02 Issue: Volume:193 Page:102-108.e1
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Shakhnovich Valentina,Smith P. Brian,Guptill Jeffrey T.,James Laura P.,Collier David N.,Wu Huali,Livingston Chad E.,Zhao Jian,Kearns Gregory L.,Benjamin Daniel K.,Berezny Katherine Y.,Wolkowiez P. Michael Cohen,Laughon Matthew M.,Paul Ian M.,Smith Michael J.,van den Anker John,Wade Kelly,Siegel David,Taylor-Zapata Perdita,Zajicek Anne,Ren Zhaoxia,Tsilou Ekaterini,Pagan Alice,Anand Ravinder,Clemons Traci,Simone Gina,Howard Lee,Weigel Jaylene,Darden Saad Nancy

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference33 articles.

1. Prevalence of childhood and adult obesity in the United States, 2011-2012;Ogden;JAMA,2014

2. Prevalence of childhood and adult obesity in the United States;Ogden;JAMA,2013

3. Weight loss and improvement of obesity-related illness in 500 US patients following laparoscopic adjustable gastric banding procedure;Spivak;Am J Surg,2005

4. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis;El-Serag;Am J Gastroenterol,2005

5. Drug dosing in obese children: a systematic review of current pharmacokinetic data;Harskamp-van Ginkel;JAMA Pediatr,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Obesity‐Related Physiological Changes on Pantoprazole Clearance in Children Using a Population Pharmacokinetic Approach;The Journal of Clinical Pharmacology;2024-08-27

2. A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator;CPT: Pharmacometrics & Systems Pharmacology;2024-07-18

3. Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population;CPT: Pharmacometrics & Systems Pharmacology;2024-06-04

4. Comparative pharmacokinetics of intravenous and subcutaneous pantoprazole in sheep and goats;The Veterinary Journal;2024-06

5. Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children;Clinical and Translational Science;2024-04